Skip to main content
OpenTrials

Clinical trial condition

Breast Cancer

Explore clinical trials studying Breast Cancer. Study availability and eligibility vary by location and protocol.

6,461 public trials 1,143 recruiting studies
Refine in advanced search Browse all conditions

Breast Cancer trial results

Active, Not Recruiting

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer

NCT05563220

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Dothan Hematology and Oncology Dothan, Alabama, United States
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • City of Hope National Medical Center Duarte, California, United States
View all 83 locations
View Trial Details
Active, Not Recruiting

A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer

NCT05852691

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Cancer Blood and Specialty Clinic Los Alamitos, California, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Novant Health Presbyterain Medical Center Charlotte, North Carolina, United States
  • Avera Cancer Institute Sioux Falls, South Dakota, United States
View all 36 locations
View Trial Details
Active, Not Recruiting

Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.

NCT00099437

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Research Site Casa Grande, Arizona, United States
  • Research Site Fountain Valley, California, United States
  • Research Site New Britain, Connecticut, United States
  • Research Site Crystal River, Florida, United States
View all 106 locations
View Trial Details
Active, Not Recruiting

Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer

NCT01872260

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Univ of California at San Diego Moores Cancer Ctr San Diego, California, United States
  • UCSF Medical Center San Francisco, California, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Massachusetts General Hospital SC-5 Boston, Massachusetts, United States
View all 25 locations
View Trial Details
Active, Not Recruiting

To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer

NCT03006172

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Massachusetts General Hospital. Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Columbia University Medical Center New York, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer

NCT05113251

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Research Site Springdale, Arkansas, United States
  • Research Site Beverly Hills, California, United States
  • Research Site Glendale, California, United States
  • Research Site Los Alamitos, California, United States
View all 145 locations
View Trial Details

Related conditions